Wondering if you have an opinions on the following 1) Chance of SCD being deemed a Class 3 device classification by the FDA following approval for Adult patients ...that would probably extend the life of their key patent another 5 yrs . Being approved for the pediatric indication should help towards a Class 3 classification
2) Fresenius buying them if / when they get approval for the adult indication ...which IMHO would increase if they got a Class 3 device classification . Fresenius currently makes their SCD cartridges I think .
Market Data 
Markets 
AI
